Medical disclaimer. This article is educational. It describes what physicians prescribe for testosterone replacement therapy — it is not dosing advice for you. Testosterone is a Schedule III controlled substance in the United States and a prescription-only medication in most countries. Do not start, stop, or change any TRT regimen based on what you read here. Talk to a licensed clinician who has reviewed your full lab work and medical history. See our full medical disclaimer.
Affiliate disclosure. This page contains affiliate links. If you book a consultation through one of them we may earn a commission at no extra cost to you. See our affiliate disclosure.
There is no single “correct” dose of testosterone replacement therapy. The right dose for you is whatever the smallest amount is that resolves your symptoms while keeping your labs in a safe, sustainable range — and that number is determined by your physician, your physiology, and your follow-up bloodwork, not by a calculator.
What we can do is show you, transparently, what dose ranges board-certified physicians at major US telehealth and clinic-based TRT providers actually prescribe in 2026, what formulations they use, how they titrate based on labs, and the reasons your prescribed dose may look very different from a friend’s. By the end of this article you should be able to walk into your first TRT consultation already knowing the right questions to ask.
Key takeaways
The most commonly prescribed TRT regimens in 2026 fall in a relatively narrow band: 100 to 200 mg per week of injectable testosterone cypionate or enanthate, split across one to three injections, with the goal of keeping total testosterone in the upper-normal physiologic range and free testosterone in the top quartile of the reference range. Topical creams and gels are typically dosed at 40 to 100 mg of testosterone applied daily, depending on absorption. Pellets deliver 800 to 1,200 mg per implant cycle, lasting roughly 3 to 6 months. Enclomiphene, an alternative for men who want to preserve fertility, is most often prescribed at 12.5 to 25 mg daily.
Inside those ranges your specific dose depends on your starting total testosterone, free testosterone, SHBG, hematocrit, estradiol, body composition, age, and how you respond clinically. Two men of the same weight can need very different doses to land in the same therapeutic window.
Why TRT dosing isn’t one-size-fits-all
TRT is unusual among prescription medications in that the target is not a fixed dose — it is a fixed result. Your physician is trying to land your hormonal labs in a window that is well-described by the American Urological Association’s Evaluation and Management of Testosterone Deficiency guideline and the Endocrine Society’s Testosterone Therapy in Men with Hypogonadism clinical practice guideline, while keeping you symptomatically improved and free of side effects.
Several variables shift how much exogenous testosterone it takes to reach that window:
Sex hormone-binding globulin (SHBG). Men with high SHBG bind more testosterone in the bloodstream, leaving less free testosterone available to tissues. They often need a slightly higher total testosterone target to feel well. Men with low SHBG (often associated with insulin resistance) may have adequate free testosterone at lower total testosterone numbers — and may run into elevated estradiol or hematocrit at standard doses.
Aromatization rate. Some men convert testosterone to estradiol more aggressively than others. A man who aromatizes heavily may need a slightly lower TRT dose, or co-management with an aromatase inhibitor, to avoid water retention, mood changes, or breast tissue tenderness.
Hematocrit response. Exogenous testosterone stimulates red blood cell production. A small subset of men respond strongly enough that their hematocrit rises above 52–54%, which raises clotting risk. Their physicians will dose lower, switch to subcutaneous injection (which produces a flatter pharmacokinetic curve), or add therapeutic phlebotomy.
Body composition and age. Larger men generally need slightly more, older men generally need slightly less. Neither is dispositive.
Goal. A man whose only symptom is low libido may resolve fully at a low dose. A man with severe fatigue, low mood, and muscle loss may need to push into the upper end of the therapeutic range to feel like himself again.
Formulation and injection frequency. A 200 mg/week dose split into two 100 mg injections produces a flatter blood-level curve than 200 mg given once weekly. Some men feel meaningfully different on the same total weekly milligrams just by changing the schedule.
This is why every reputable TRT provider re-tests bloodwork at six to eight weeks and again at six months, and adjusts dosing from there. A starting dose is a hypothesis. The labs are the test.
The most commonly prescribed TRT formulations in 2026
Across major US telehealth and clinic-based providers — including OralOnly, Regenics, Inception Health, Telemedical Services Maximus, Marek Health, Henry Meds, and traditional men’s health urology practices — five formulations dominate prescribing in 2026.
Per FTC: Affiliate links. We may earn a commission if you book or buy through them, at no extra cost to you.
Testosterone cypionate (intramuscular or subcutaneous)
The most-prescribed TRT formulation in the United States. Cypionate is a long-acting ester with a half-life of approximately 8 days, which makes once- or twice-weekly dosing practical.
Typical prescribed range: 100 to 200 mg per week. Lower starting doses (80–100 mg/week) are common for men over 60 or men with elevated baseline hematocrit. Higher doses (180–200 mg/week) are typically reserved for men who didn’t reach symptom resolution or therapeutic labs at lower doses.
Typical schedules: Once weekly is the simplest and was the standard for decades. Twice weekly (every 3.5 days) and three times weekly (every other day, “E2D”) have become more common at telehealth clinics over the last five years because they produce flatter blood-level curves with fewer mood and energy fluctuations between injections.
Subcutaneous vs intramuscular. Both work. Sub-Q injection — typically into the abdomen or thigh fat with a smaller insulin-style needle — produces a slower release, lower peak, and is preferred by many men who experience side effects with IM dosing. The American Society of Andrology has noted comparable efficacy.
Cost. Cypionate is genericized and typically the cheapest TRT formulation. Telehealth clinic pricing in 2026 ranges from roughly $129 to $249 per month including labs, provider time, and the medication.
Testosterone enanthate (intramuscular or subcutaneous)
Pharmacokinetically very similar to cypionate (half-life ~7 days). In the US, cypionate is more common; in Europe and many other countries, enanthate is the standard. Typical prescribed range: 100 to 200 mg per week, dosed identically to cypionate.
Testosterone topical cream and gel
Daily application to the shoulders, upper arms, or scrotum. Absorption varies significantly between men — typically 10 to 20% of applied dose reaches systemic circulation, and scrotal application can be 5 to 10 times more efficient than skin application due to thinner skin and higher blood flow.
Typical prescribed range: 40 to 100 mg of testosterone applied daily for shoulder/arm application; lower doses (20–50 mg) for scrotal application. Brand-name examples include AndroGel, Testim, and Fortesta; compounded creams (often through clinics like Regenics or Marek) allow dose customization.
Trade-offs. Creams avoid injections and produce relatively stable blood levels with daily use. The downsides are absorption variability, transfer risk to partners and children, and higher monthly cost than injectable cypionate.
Testosterone pellets
Subcutaneous pellet implants placed in the gluteal fat in a brief in-office procedure. Pellets release testosterone steadily over 3 to 6 months.
Typical prescribed range: 800 to 1,200 mg total testosterone per implant cycle, with the higher end reserved for men who metabolize quickly. Brand examples include Testopel.
Trade-offs. No daily or weekly dosing required, very stable blood levels through the cycle. The downside is loss of dose-adjustment flexibility — once the pellet is in, you live with that dose for months. Pellets can also extrude or become infected. Cost is typically the highest of the four major modalities.
Enclomiphene (oral)
Not technically TRT — enclomiphene is a selective estrogen receptor modulator that stimulates the body’s own LH and FSH production, raising endogenous testosterone. It’s prescribed instead of TRT when fertility preservation is a priority, or as an alternative for younger men with secondary hypogonadism.
Typical prescribed range: 12.5 to 25 mg daily, oral. Maximus is the largest US telehealth provider building a practice around enclomiphene. Some clinics combine enclomiphene with a low-dose injectable for combination protocols.
Trade-offs. Preserves fertility (TRT typically suppresses sperm production within months). Smaller magnitude of testosterone increase than injectable TRT. Not effective for primary hypogonadism (testicular failure), where the testes can’t respond to LH.
How clinicians actually titrate
A typical first-year TRT regimen looks like this:
- Pre-treatment labs. Total testosterone (drawn early morning, fasting), free testosterone, SHBG, estradiol (sensitive assay), LH, FSH, prolactin, CBC for hematocrit, CMP, lipid panel, PSA (for men over 40), and TSH.
- Starting dose. Usually a conservative dose: 100 to 140 mg/week of cypionate or enanthate, split twice weekly, is the most common starting protocol in 2026 telehealth practice. Cream and pellet starting doses scale similarly.
- Six-to-eight week labs. Trough total and free testosterone (drawn just before next injection, to capture the lowest level of the cycle), hematocrit, and estradiol. Symptoms reviewed.
- First titration. If the patient is asymptomatic and labs are mid-range, dose stays the same. If symptoms persist and labs are still low, dose increases by 20 to 40 mg/week. If hematocrit is climbing or estradiol is symptomatically high, dose decreases or is split into more frequent injections.
- Six-month labs. Full panel including PSA. Continued titration if needed.
- Annual labs thereafter for a stable patient.
The treatment target most US clinicians shoot for in 2026 is total testosterone in the 600 to 1,000 ng/dL trough range and free testosterone in the upper quartile of the reference range, with hematocrit kept below 52–54% and estradiol kept in a range where the patient is symptomatically well (there is no universally agreed-upon “ideal” estradiol number).
Why your prescribed dose probably won’t match someone else’s
The single most common mistake men make researching TRT online is anchoring to a specific number — usually 200 mg/week, because that’s the dose most often discussed on forums — and treating any deviation as wrong.
Two men of identical body weight can land in the exact same total testosterone window on doses that differ by 50% or more, because of differences in SHBG, aromatization rate, fat mass, body composition, age, and the exact pharmacokinetics of how their body handles the chosen ester. Forum protocols also disproportionately come from younger lifters using TRT for performance, not from the larger and quieter population of men in their 40s, 50s, and 60s who are simply trying to feel like themselves again at the lowest effective dose.
Trust your labs and your symptom response, not the number someone else uses.
Common ancillaries
Many TRT protocols include one or more supporting medications.
Human chorionic gonadotropin (HCG). Mimics LH and keeps the testes producing testosterone (and, more importantly, sperm) on TRT. Typical prescribed dose: 250 to 500 IU subcutaneously two or three times per week. Used by men who want to preserve fertility while on TRT, or by men who experience testicular atrophy and want to maintain testicular size.
Anastrozole (aromatase inhibitor). Reduces conversion of testosterone to estradiol. Most modern protocols use it sparingly — only when estradiol is symptomatically elevated, not preventively. Typical prescribed dose: 0.25 to 0.5 mg, one to three times per week. Over-suppression of estradiol causes its own set of problems (joint pain, mood, lipid changes).
Enclomiphene as adjunct. Some clinics use 12.5 mg daily enclomiphene alongside low-dose injectable testosterone, particularly for younger men who want fertility preservation without leaving TRT entirely.
Vitamin D, zinc, magnesium. Frequently checked and supplemented because deficiency can blunt the response to TRT or worsen baseline symptoms.
The “more is better” trap
The most common reason men get into trouble on TRT is chasing a number — pushing total testosterone to 1,500 ng/dL or higher in pursuit of more energy, more muscle, or more libido.
Above the upper end of physiologic range, the marginal benefit of additional testosterone falls off quickly while side-effect risk climbs sharply: erythrocytosis, hypertension, sleep apnea, mood instability, acne, hair loss in genetically predisposed men, and — at sustained supraphysiologic doses — cardiovascular events. The 2023 TRAVERSE trial published in the New England Journal of Medicine found that TRT prescribed to physiologic targets is cardiovascular-safe in middle-aged men with confirmed hypogonadism. That safety profile does not extend to the supraphysiologic doses common in performance-driven protocols.
The doctors who run the major TRT clinics — and the ones we recommend — uniformly target physiologic, not supraphysiologic, levels. If a clinic is offering to dose you to 1,500 ng/dL because “you’ll feel amazing,” that is a red flag, not a feature.
Questions to ask your doctor
When you start TRT — whether through telehealth or in-person — these are the questions that separate a careful provider from a careless one.
- What total testosterone, free testosterone, hematocrit, and estradiol numbers are you targeting for me, and why?
- When will we re-test labs?
- How will you adjust my dose if hematocrit rises above 52%?
- Will you prescribe HCG or enclomiphene to preserve fertility if I want children later?
- What are your protocols if my estradiol becomes symptomatically high?
- How frequently can I reach you between appointments if I have a question or side effect?
- Will my care be supervised by a physician (MD or DO), or by a nurse practitioner alone?
- What’s your refund and cancellation policy?
If a provider can’t answer those clearly, keep shopping.
Where to get prescribed TRT in 2026
Three ways to access legitimate TRT in the US.
Telehealth TRT clinics. The fastest-growing channel. National telehealth providers handle labs (drawn at a local Quest or LabCorp), provider video consults, and ship medication directly to you. Pricing is typically all-inclusive at $129 to $349 per month. Major players in 2026 include Regenics (our partner — direct-to-patient compounded protocols), Hone Health, Maximus (enclomiphene-focused), Marek Health (higher-end), and Henry Meds.
Traditional urology and endocrinology practices. The original path. Higher friction, longer wait times, but covered by insurance for many patients with documented hypogonadism. Best fit if you have complicating factors — fertility concerns, history of cancer, cardiovascular disease — that benefit from in-person care.
Concierge men’s health clinics. Local clinics that combine in-person visits with personalized protocols. Highest cost, highest level of attention. Common in major US metros.
For most men starting TRT in 2026 with no major comorbidities, telehealth is the pragmatic starting point. Read our Best Online TRT Clinics in 2026 review for a full comparison.
Ready to talk to a doctor? Our partner Regenics offers a free 15-minute consultation with a licensed clinician to review your symptoms and decide whether labs and TRT are appropriate for you. Book your free consult →
Sources and further reading
- American Urological Association. Evaluation and Management of Testosterone Deficiency. Most recent guideline available at auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline.
- Bhasin S, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. (Endocrine Society)
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023.
- US Food and Drug Administration. Testosterone and cardiovascular risk: drug safety communications.
- Mayo Clinic. Testosterone therapy: Potential benefits and risks as you age.
